APPENDICES. A systematic review and economic model of the ...

More documents

Recommendations

Info

172 Appendix 3 Reference Reason for exclusion Klein et al., 2002209 No relevant outcomes Kollins et al., 2001 210 Inappropriate outcomes/predominantly adult or non-human population Konrad et al., 2004 211 No relevant outcomes Kurlan and Goldberg, 2002 212 Inappropriate population: co-morbid disorder. Lewis et al., 2003 213 Inappropriate population: co-morbid disorder Li and Chen, 1999 214 Required translation Lieberman and Christophersen, 2000 215 Abstract only Loo et al., 2003 216 No relevant outcomes Lopez et al., 2003 217 Inadequate trial duration Malone et al., 2002 218 No relevant outcomes Mannuzza et al., 2003 219 Inappropriate population: alternative condition Manos et al., 2000 220 Abstract only McBurnett, 2003 221 Inadequate trial duration Michelson et al., 2001 222 Abstract only Michelson et al., 2001 223 Abstract only Mohammadi et al., 2004 224 Unlicensed comparator/no placebo Montiel Nava et al., 2002 225 Delayed receipt of paper Newcorn, 2003 226 Abstract only Nolan et al., 1999 227 Inappropriate population: co-morbid disorder Overtoom et al., 2003 228 No relevant outcomes Palumbo and Starr, 2003 229 Abstract only Pearson et al., 2003 230 Inappropriate population: co-morbid disorder Pearson et al., 2004 231 Inappropriate population: co-morbid disorder Pearson et al., 2004 232 Inappropriate population: co-morbid disorder Pelham et al., 2002 233 Inadequate data presentation Rapport et al., 2002 234 No relevant outcomes Rhodes, et al., 2003 235 Abstract only Riyad et al., 2002 236 Inappropriate outcomes/inappropriate comparators Rubia et al., 2003 237 No relevant outcomes Schachter et al., 2001 238 Primary studies assessed for inclusion Scheres et al., 2003 239 No relevant outcomes Sharp et al., 1999 149 Inadequate data presentation Sharp et al., 2003 240 Delayed receipt of paper Shaughnessy, 1999 241 Abstract only Smith et al., 2000 242 Primary studies assessed for inclusion Smith et al., 2004 243 No relevant outcomes Spencer, 2004 244 Inappropriate population: co-morbid disorder Sunohara, 1999 245 No relevant outcomes Swanson et al., 2000 246 Abstract only Swanson, 2000 247 Abstract only Swanson et al., 1998 248 Inadequate data presentation Swanson et al., 1998 249 Inadequate data presentation Swanson et al., 2002 250 Inadequate trial duration Swanson et al., 1999 251 Inadequate trial duration Swanson et al., 2000 252 Abstract only Swanson et al., 2002 253 Abstract only Szobot et al., 2003 254 No relevant outcomes Tenreiro, 2001 255 No relevant outcomes The Tourette’s Syndrome Study Group 2002 256 Inappropriate population: co-morbid disorder Tillery et al., 2000 257 Inappropriate population: co-morbid disorder van der Meere et al., 1999 258 No relevant outcomes Weiss et al., 2003 144 Abstract only Wernicke et al., 2001 259 Abstract only Wernicke et al., 2001 260 Abstract only Wernicke et al., 2001 261 Abstract only Whalen et al., 1989 262 No relevant outcomes Wigal, 2002 263 Abstract only Wigal et al., 1998 264 No relevant outcomes Wigal et al., 2003 265 Delayed receipt of paper continued
Reference Reason for exclusion Wigal et al., 2002266 Wigal et al., 1999 267 Wilens, 2000 268 Wilens et al., 2003 269 Wilens et al., 2004 270 Wolraich, 2000 271 © Queen’s Printer and Controller of HMSO 2006. All rights reserved. Health Technology Assessment 2006; Vol. 10: No. 23 Abstract only Inadequate data presentation (data not presented by drug) Abstract only Inadequate data presentation (data not presented by drug) No relevant outcomes Abstract only 173
Page 1 and 2: Appendices A systematic review and
Page 3 and 4: Clinical effectiveness information
Page 5 and 6: Searches for systematic reviews in
Page 7 and 8: 19. methyl phenidate.mp. 20. methyl
Page 9 and 10: 43. attention deficit$.mp. 44. 42 o
Page 11 and 12: MEDLINE in-process and other non-in
Page 13 and 14: PsycINFO (1967-July 2004) Searched:
Page 15 and 16: next aminopropane) or dynaphenyl or
Page 17 and 18: or ritaline or riphenidate or rital
Page 19: System for Information on Grey Lite
Page 22 and 23: 166 Appendix 2 S hyperkinetic S imp
Page 24 and 25: 168 Appendix 2 19. (eq5d or eq 5d o
Page 26 and 27: 170 Appendix 2 14. (person trade of
Page 31: Appendix 4 © Queen’s Printer and
Page 34 and 35: 178 Appendix 5 8. Was the statistic
Page 36 and 37: 180 Appendix 6 Cost-effectiveness R
Page 38 and 39: 182 Appendix 7 Appropriateness of m
Page 40 and 41: 184 Appendix 7 Sensitivity analysis
Page 42 and 43: 186 Appendix 7 Sensitivity analysis
Page 44 and 45: 188 Appendix 8 Probability cost-eff
Page 47 and 48: Appendix 10 © Queen’s Printer an
Page 49 and 50: Health state Responder to ATX, no s
Page 51 and 52: Health state Responder to IR-MPH, R
Page 53 and 54: Health state Responder to ER-MPH, R
Page 55: #Baseline shift random effects mode
Page 58 and 59: 202 Appendix 12 Study Intervention
Page 62 and 63: 206 Appendix 12 Core symptoms Educa
Page 78 and 79:
222 Appendix 12 Core symptoms Educa
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
228 Appendix 12 Study Intervention
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222:
366 Appendix 13 Study characteristi
show all

APPENDICES. A systematic review and economic model of the ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?